Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomerica in campaign against colorectal cancer:

This article was originally published in Clinica

Executive Summary

Some 17,000 EZ-Detect occult blood tests have been bought from Biomerica as part of the company's month-long colorectal screening campaign, which it is carrying out in Mississippi with Familymeds Pharmacy. The Newport Beach, California-based company has conducted similar campaigns in Philadelphia, Detroit, Baltimore and Hartford. "We are making considerable headway in establishing the role of EZ Detect in combating the nation's number two cancer killer, colorectal cancer," said Francis Capitiano, president of Biomerica's diagnostics division. "These colorectal screening campaigns have become a significant source of revenue for our company," he added.

Topics

UsernamePublicRestriction

Register

MT064147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel